A study explores how people with psoriasis use digital media, revealing benefits, pitfalls, and gaps in physician-patient communication.

FDA intensifies efforts against misleading drug advertisements, aiming for transparency and accountability in pharmaceutical marketing practices.

New demands to follow the most favored nation executive order could lead to some compliance but it is unknown just how effective they will be across all health care.

DeepSeek-R1 was able to improve diagnosis management in these subspecialties while also lowering operation costs.

Selumetinib's approval now includes children as young as 1 year old with NF1 and symptomatic, inoperable plexiform neurofibromas. The drug targets the RAS/MEK/ERK pathway, providing a non-surgical ...

The Breast Cancer Index and artificial intelligence–assisted mammograms are tools that can help mitigate symptoms and reassure patient insecurities of women with breast cancer post-treatment.

Experts discuss innovative strategies to enhance dental care access in underserved Pennsylvania communities, emphasizing collaboration and cultural sensitivity in outreach efforts.

An expert discusses the evolution of ROS1 testing in non-small cell lung cancer, highlighting the shift from FISH-based methods to comprehensive next-generation sequencing of both tissue and plasma, ...

Cilta-cel demonstrates superior efficacy and durability in treating high-risk myeloma, balancing effectiveness with safety concerns for patients.

Among patients with hematologic malignancies who were diagnosed with COVID-19, about one-quarter experienced critical illness, and most of those patients died.

The authors discuss the need to repair a house divided among research, health care, and the multisector health community.

A new report from the National Alliance calls for data transparency and PBM reform to combat rising care costs, enhance ...